Barely Significant
← all phrases

“approaching significance”

2,641 sentences · 2,641 papers · 3,385 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

approaching significancep = 0.0571.1× alphagold
All contextualized models show statistically significant improvement on Word2Vec (in all cases, p < 0.0005); and very similar results emerge regarding TransE, since the difference in scores is statistically significant for all models (BERT base: p = 0.0021, BERT large: p = 0.0004, LUKE base: p = 0.0054, LUKE large: p = 0.0085) but ELMO, which is approaching significance ( p = 0.057).
approaching significancep = 0.0571.1× alphagold
Moreover, patients without VC in both groups more often exhibited hyperphosphatemia (>1.9 mmol/L) than those without VC, with the difference approaching significance ( p = 0.057).
approaching significancep = 0.0571.1× alphagold
In general, though only approaching significance, participants exhibited higher variations in the GEM direction in the DT-paper ( p = 0.057) condition compared to the ST condition, while these variations slightly increased in the DT-phone ( p = 0.197) and DT-glass ( p = 0.374) conditions ( Fig 6 , top).
approaching significancep = 0.0571.1× alphagold
Nonparametric testing on the three groups (i.e., Aβ‐pos, stable Aβ‐neg, and progressive Aβ‐neg) highlighted significant differences in the AC (Kruskal‐Wallis H (2) = 6.08, p = 0.048), AT (Kruskal‐Wallis H (2) = 7.66, p = 0.02), FI (Kruskal‐Wallis H (2) = 6.24, p = 0.044), MTA (Kruskal‐Wallis H (2) = 13.1, p = 0.001), ERICA (Kruskal‐Wallis H (2) = 16.46, p < 0.001), PA (Kruskal‐Wallis H (2) = 6.73, p = 0.03) scales, with the PVH approaching significance (Kruskal‐Wallis H (2) = 5.72, p = 0.057).
approaching significancep=0.0571.1× alphagold
1 In the total RA population, the largest differences in baseline antibody positivity between non-remission and remission patients, and correspondingly the highest OR, were observed at 9 months, with the non-remission SDAI therapy response approaching significance (22.7% non-rem vs 9.3% rem; OR (95% CI): 2.86 (0.97 to 10.5), p=0.057 for multivariable analysis) ( table 6 ).